Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Meredith

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Circulation. Cardiovascular Interventions|March 1, 2021
Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting StentAjay J Kirtane, Robert Stoler, Robert Feldman, et al.
The International Journal of Cardiovascular Imaging|November 24, 2011
Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffoldSalvatore Brugaletta, Josep Gomez-Lara, Hector M Garcia-Garcia, et al.
Circulation|November 25, 2010
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, John A Ormiston, et al.
Journal of the American College of Cardiology|October 1, 2011
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, Dariusz Dudek, et al.
Circulation. Cardiovascular Interventions|October 11, 2012
First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality studyJohn A Ormiston, Patrick W Serruys, Yoshinobu Onuma, et al.
JACC. Cardiovascular Interventions|December 20, 2014
Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)Yoshinobu Onuma, Patrick W Serruys, Takashi Muramatsu, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 3, 2013
Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 monthsPatrick W Serruys, Yoshinobu Onuma, Hector M Garcia-Garcia, et al.
JACC. Cardiovascular Interventions|March 26, 2013
The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stentMichael Haude, Stephen W L Lee, Stephen G Worthley, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 18, 2015
Impact of body mass index on long-term clinical outcomes after second-generation drug eluting stent implantation: Insights from the international global RESOLUTE programRoberto Diletti, Hector M Garcia-Garcia, Christos Bourantas, et al.
Journal of the American College of Cardiology|July 9, 2011
6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mmRoberto Diletti, Yoshinobu Onuma, Vasim Farooq, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Circulation. Cardiovascular Interventions|March 1, 2021
Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting StentAjay J Kirtane, Robert Stoler, Robert Feldman, et al.
The International Journal of Cardiovascular Imaging|November 24, 2011
Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffoldSalvatore Brugaletta, Josep Gomez-Lara, Hector M Garcia-Garcia, et al.
Circulation|November 25, 2010
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, John A Ormiston, et al.
Journal of the American College of Cardiology|October 1, 2011
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, Dariusz Dudek, et al.
Circulation. Cardiovascular Interventions|October 11, 2012
First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality studyJohn A Ormiston, Patrick W Serruys, Yoshinobu Onuma, et al.
JACC. Cardiovascular Interventions|December 20, 2014
Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)Yoshinobu Onuma, Patrick W Serruys, Takashi Muramatsu, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 3, 2013
Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 monthsPatrick W Serruys, Yoshinobu Onuma, Hector M Garcia-Garcia, et al.
JACC. Cardiovascular Interventions|March 26, 2013
The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stentMichael Haude, Stephen W L Lee, Stephen G Worthley, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 18, 2015
Impact of body mass index on long-term clinical outcomes after second-generation drug eluting stent implantation: Insights from the international global RESOLUTE programRoberto Diletti, Hector M Garcia-Garcia, Christos Bourantas, et al.
Journal of the American College of Cardiology|July 9, 2011
6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mmRoberto Diletti, Yoshinobu Onuma, Vasim Farooq, et al.
Pageof 5